Nanjing Lingnuo Biomedical Technology Research Institute Co., Ltd.

To study the pharmacokinetic characteristics of a single oral administration of phloroglucinol orodisintegrating tablets (test preparation T, specification: 80 mg) provided by Nanjing Lingnuo Biomedical Technology Research Institute Co., Ltd. to healthy subjects under fasting and postprandial conditions and a single oral administration of phloroglucinol orodisintegrating tablets (reference preparation R, specification: 80 mg) certified by Teva Sante under the same conditions, evaluate the bioequivalence and safety of the two preparations, and provide a basis for the registration application of the test preparation.